News from NORD

NORD Advocates for Iowa Co-pay Choice Bill

NORD has been advocating for the Iowa Co-pay Choice Bill (SSB 3004). This legislation would help with rising out-of-pocket costs. Specifically, SSB 3004 gives choice and co-pay predictability to Iowa families by requiring that insurance providers offer a minimum number of plans that provide a traditional co-pay option, as opposed to co-insurance. NORD will continue to advocate for this legislation throughout February.

Recommended Reading

January 12 Is Deadline for Rare Impact Awards Nominations
MDedge Hematology and Oncology
NORD Awards Five Research Grants
MDedge Hematology and Oncology
Visit NORD’s Website to Learn About Current or Future Research Funding Opportunities
MDedge Hematology and Oncology
NORD Launches Year-Long 35th Anniversary Observance
MDedge Hematology and Oncology
NORD Provides Update on Tax Cuts and Jobs Act
MDedge Hematology and Oncology
FDA Issues Guidance for More Efficient Approach to Drug Development for Rare Pediatric Diseases
MDedge Hematology and Oncology
NIH Undiagnosed Diseases Network to Offer Grand Rounds Webinar Series
MDedge Hematology and Oncology
NORD to Moderate Panel at NIH Rare Disease Day Event
MDedge Hematology and Oncology
Rare Disease Day Events Planned for Campuses, Hospitals, and State Legislatures
MDedge Hematology and Oncology
Letter to Congress: NORD and Others Oppose “Right to Try”
MDedge Hematology and Oncology